[Hy BioPharma Inc.] Also see "Hy BioPharma Inc." - Scrip, 1 July, 2008. is developing hypericin phototherapeutics for cancers and autoimmune disorders. The Israeli/US start-up is also in Phase I/IIb trials for an oral formulation of hypericin for possible use in combination therapy with Temodar for the treatment of glioblastoma.
MedGenesis Therapeutix Inc. Also see "MedGenesis Therapeutix Inc." - Scrip, 1 July, 2008. is developing convection-enhanced delivery, a...